Deutsche Bank’s Boundless Bio BOLD Stock Holding History

Deutsche Bank’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-97	Closed	-$281	–	3650
2024 Q4	$281	Buy	+97	New	+$283	﹤0.01%	3586

Other funds holding BOLD

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank's BOLD Position: Q1 2025 in Review

Deutsche Bank sold out of Boundless Bio (BOLD) in Q1 2025, closing a stake of 97 shares — an estimated $281 sold.

Deutsche Bank first reported a position in BOLD in Q4 2024 and held it in 1 quarter. The position peaked at $281 in Q4 2024. 54 funds tracked by Wall St. Rank hold BOLD as of Q1 2025.

Deutsche Bank reported no remaining Boundless Bio position as of Q1 2025 after selling out during the quarter.
Deutsche Bank sold 97 Boundless Bio shares in Q1 2025, an estimated $281.
Deutsche Bank first reported a position in Boundless Bio in Q4 2024 and held it in 1 quarter.
Deutsche Bank's Boundless Bio position peaked at $281 in Q4 2024.
54 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2025.

Based on Deutsche Bank's 13F filing for Q1 2025, filed 9 May 2025.